Supratherapeutic concentrations of cilostazol inhibits β-amyloid oligomerization in vitro
Keywords: Aβ; amyloid β-protein; AD; Alzheimer's disease; APP; amyloid precursor protein; APS; ammonium persulfate; αS; α-synuclein; CREB; cyclic adenosine monophosphate response element-binding protein; CSZ; cilostazol; DMTs; disease-modifying therapies; EM; e